Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Pediatrics

Volumn 108, Issue 5, 2001, Pages

  Salmaso, S ^a   Mastrantonio, P ^a   Tozzi, A E ^a   Stefanelli, P ^a   Anemona, A ^a   Ciofi degli Atti, M L ^a   Giammanco, A ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

AGE; ARTICLE; BLOOD; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; ITALY; MALE; PERTUSSIS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; ITALY; MALE; POPULATION SURVEILLANCE; WHOOPING COUGH;

MLCS; MLOWN;

EID: 0035512245     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.108.5.e81     Document Type: Article

References (0)